iLIVER Open Access Editor-in-Chief: Jiahong Dong
Home iLIVER All Issues Volume 3 Issue 4
Volume 3 Issue 4, December 2024
Cover
Back cover
Cover
Back cover
Contents(PDF)
12 articles
Previous Issue
|
Next Issue
Editorial | Open Access
Multiomic predictors for regression of cirrhosis: Clinical implications and future directions
Binghua Li, Decai Yu
Published: 07 September 2024
2024, 3(4): 100116
Editorial | Open Access
Speaking the same language in predicting Small-for-Size Syndrome in living donor liver transplantation
Alfred Wei-Chieh Kow
Published: 09 November 2024
2024, 3(4): 100129
Review | Open Access
Arginine methylation modification in the malignant progression of benign and malignant liver diseases
Jie-Zuo Huang, Bei-Ning Qiao, Dang-Chi Li, [...], Qiu-Rong Wei, Zi-Jian Zhang << Fewer
Published: 30 September 2024
2024, 3(4): 100124
Review | Open Access
New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products
Pooja Yadav, Khushi Quadri, Renu Kadian, [...], Aafrin Waziri, Pankaj Agrawal, Md Sabir Alam << Fewer
Published: 08 November 2024
2024, 3(4): 100131
Original Article | Open Access
Gd-EOB-DTPA-enhanced MRI proves advantageous in selecting surgical candidates for patients with early-stage hepatocellular carcinoma: An analysis in terms of oncological outcomes
Zhiwei Ye, Jing Zhao, Dandan Hu, [...], Zhoutian Yang, Jinbin Chen, Li Xu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang << Fewer
Published: 18 September 2024
2024, 3(4): 100117
Original Article | Open Access
Evaluating the role of IER3+ macrophages in the prognosis of liver fibrosis by bulk and single-cell transcriptional analyses
Ling Chu, Junbo Zhang, Ruoyu Meng, Quan Zhuang
Published: 07 November 2024
2024, 3(4): 100132
Original Article | Open Access
WGCNA combined with machine learning to explore potential biomarkers and treatment strategies for acute liver failure, with experimental validation
Xinyan Wu, Xiaomei Zheng, Gang Ye
Published: 13 November 2024
2024, 3(4): 100133
Protocol | Open Access
Danning tablets for the treatment of multiple gallbladder polyps: Study protocol of multicentre, randomised, open-labelled, controlled trial
Tian Yang, Ming-Da Wang, Gui-Lin Xie, [...], Xiong-Hua Wang, Liu Zheng, Li-Min Wang, Guang-Fa Xiao, Yong-Qing Yang, Chao Li, Alfred Wei Chieh Kow, Feng Shen << Fewer
Published: 06 November 2024
2024, 3(4): 100127
Commentary | Open Access
Increased attention to women with drug-induced liver injury: Risk factors and early intervention
Xiaoru Sun, Xinrong Zhang, Muyun Liu
Published: 30 October 2024
2024, 3(4): 100125
Commentary | Open Access
Comment on “Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab”
Binghua Li, Qiang Wang, Weiwei Hu, [...], Huan Li, Peng Yan, Yajuan Cao, Decai Yu << Fewer
Published: 07 November 2024
2024, 3(4): 100130
Commentary | Open Access
Full robotic whole graft liver transplantation: Is a new era coming?
Yipeng Pan, Jimin Liu, Qi Ling
Published: 06 November 2024
2024, 3(4): 100128
Letters to Editor | Open Access
Reply to Dr. Sun et al.: Female DILI patients need more clinical attention
Yu-Ting Xiong, Chun-Yan Wang, Dong Ji
Published: 06 November 2024
2024, 3(4): 100126